Novo Holdings

New York, New York
Firm Location:New York, New York • San Francisco, California • Boston, Massachusetts • Copenhagen, Denmark • United Kingdom
Investor Firms That Co-Invest with Novo Holdings
Novo Holdings Team
Photo of Raymond Camahort, Principal at Novo Holdings
Raymond Camahort
Novo Holdings·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Seed), Investors in Chemicals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Chemicals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Series B), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Pre-seed), Investors in Chemicals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Chemicals (Pre-seed), Investors in BioTech (Pre-seed)
Photo of Nik Economopoulos, Investor at Novo Holdings
Nik Economopoulos
Novo Holdings·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom
Photo of Shawnalea Frazier, Principal at Novo Holdings
Shawnalea Frazier
Novo Holdings·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Photo of Kenneth Harrison, Novo Holdings
Kenneth Harrison
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Hongjie Hu, Partner at Novo Holdings
Hongjie Hu
Novo Holdings·Partner
Sweet spot: $10.0M
Range: $5.0M - $15.0M
Investors in Singapore, Investors in Canada, Investors in United Kingdom, Investors in France, Investors in Europe, Investors in United States
Photo of Heather Ludvigsen, Novo Holdings
Heather Ludvigsen
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Copenhagen (Denmark)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Pre-seed), Investors in FinTech (Pre-seed), Investors in FinTech (Series A), Investors in FinTech (Seed)